Nutrition in cardioskeletal health

Advances in Nutrition

Volumn 7, Issue 3, 2016, Pages 544-555

  Hill Gallant, Kathleen M ^a   Weaver, Connie M ^a   Towler, Dwight A ^b   Thuppal, Sowmyanarayanan V ^a   Bailey, Regan L ^a,c  

^a PURDUE UNIVERSITY   (United States)

^b UNIVERSITY OF TEXAS SOUTHWESTERN MEDICAL CENTER   (United States)

^c NATIONAL INSTITUTES OF HEALTH   (United States)

Author keywords

Bone health; Calcium; Cardiovascular diseases; Phosphorus; Vitamin D

Indexed keywords

CALCIUM; FIBROBLAST GROWTH FACTOR; FIBROBLAST GROWTH FACTOR 23; MINERAL; PARATHYROID HORMONE; PHOSPHORUS; VITAMIN D;

BONE; CARDIOVASCULAR DISEASES; DIET; HEALTH DISPARITY; HEART; HUMAN; METABOLISM; OSTEOPOROSIS;

BONE AND BONES; CALCIUM; CARDIOVASCULAR DISEASES; DIET; FIBROBLAST GROWTH FACTORS; HEALTH STATUS DISPARITIES; HEART; HUMANS; MINERALS; OSTEOPOROSIS; PARATHYROID HORMONE; PHOSPHORUS; VITAMIN D;

EID: 84971457533     PISSN: 21618313     EISSN: 21565376     Source Type: Journal    
DOI: 10.3945/an.115.011189     Document Type: Article

References (134)

1. Demer LL, Tintut Y. Vascular calcification: Pathobiology of a multifaceted disease. Circulation 2008;117:2938-48.
2. Virchow R. Cellular pathology: As based upon physiological and pathological histology: Lecture XVI-Atheromatous affection of arteries. 1858. Nutr Rev 1989;47:23-5.
3. Mayerl C, Lukasser M, Sedivy R, Niederegger H, Seiler R, Wick G. Atherosclerosis research from past to present: On the track of two pathologists with opposing views, Carl von Rokitansky and Rudolf Virchow. Virchows Arch 2006;449:96-103.
4. Mönckeberg JG. Über die reine mediaverkalkung der extremitätenarterien und ihr verhalten zur arteriosklerose. Virchows Arch Pathol Anat 1903;171:141-67.
5. Greenwald SE. Ageing of the conduit arteries. J Pathol 2007;211:157-72.
6. Thompson B, Towler DA. Arterial calcification and bone physiology: Role of the bone-vascular axis. Nat Rev Endocrinol 2012;8:529-43.
7. Westerhof N, Lankhaar JW, Westerhof BE. The arterial Windkessel. Med Biol Eng Comput 2009;47:131-41.
8. King KS, Chen KX, Hulsey KM, McColl RW, Weiner MF, Nakonezny PA, Peshock RM. White matter hyperintensities: Use of aortic arch pulse wave velocity to predict volume independent of other cardiovascular risk factors. Radiology 2013;267:709-17.
9. Silbert LC, Dodge HH, Perkins LG, Sherbakov L, Lahna D, Erten-Lyons D, Woltjer R, Shinto L, Kaye JA. Trajectory of white matter hyperintensity burden preceding mild cognitive impairment. Neurology 2012;79:741-7.
10. Cheng SL, Ramachandran B, Behrmann A, Shao JS, Mead M, Smith C, Krchma K, Bello Arredondo Y, Kovacs A, Kapoor K, et al. Vascular smooth muscle LRP6 limits arteriosclerotic calcification in diabetic LDLR2/2 mice by restraining noncanonical Wnt signals. Circ Res 2015;117:142-56.
11. Cheng SL, Behrmann A, Shao JS, Ramachandran B, Krchma K, Bello Arredondo Y, Kovacs A, Mead M, Maxson R, Towler DA. Targeted reduction of vascular Msx1 and Msx2 mitigates arteriosclerotic calcification and aortic stiffness in LDLR-deficient mice fed diabetogenic diets. Diabetes 2014;63:4326-37.
12. Engler AJ, Sen S, Sweeney HL, Discher DE. Matrix elasticity directs stem cell lineage specification. Cell 2006;126:677-89.
13. Chen JH, Simmons CA. Cell-matrix interactions in the pathobiology of calcific aortic valve disease: Critical roles for matricellular, matricrine, and matrix mechanics cues. Circ Res 2011;108:1510-24.
14. Guzman RJ, Brinkley DM, Schumacher PM, Donahue RM, Beavers H, Qin X. Tibial artery calcification as a marker of amputation risk in patients with peripheral arterial disease. J Am Coll Cardiol 2008;51:1967-74.
15. Guzman RJ, Bian A, Shintani A, Stein CM. Association of foot ulcer with tibial artery calcification is independent of peripheral occlusive disease in type 2 diabetes. Diabetes Res Clin Pract 2013;99:281-6.
16. Mohler, ER III, Gannon F, Reynolds C, Zimmerman R, Keane MG, Kaplan FS. Bone formation and inflammation in cardiac valves. Circulation 2001;103:1522-8.
17. Fadini GP, Rattazzi M, Matsumoto T, Asahara T, Khosla S. Emerging role of circulating calcifying cells in the bone-vascular axis. Circulation 2012;125:2772-81.
18. Sacchetti B, Funari A, Michienzi S, Di Cesare S, Piersanti S, Saggio I, Tagliafico E, Ferrari S, Robey PG, Riminucci M, et al. Self-renewing osteoprogenitors in bone marrow sinusoids can organize a hematopoietic microenvironment. Cell 2007;131:324-36.
19. Boström K, Watson KE, Horn S, Wortham C, Herman IM, Demer LL. Bone morphogenetic protein expression in human atherosclerotic lesions. J Clin Invest 1993;91:1800-9.
20. Reynolds JL, Skepper JN, McNair R, Kasama T, Gupta K, Weissberg PL, Jahnen-Dechent W, Shanahan CM. Multifunctional roles for serum protein fetuin-a in inhibition of human vascular smooth muscle cell calcification. J Am Soc Nephrol 2005;16:2920-30.
21. Jono S, Peinado C, Giachelli CM. Phosphorylation of osteopontin is required for inhibition of vascular smooth muscle cell calcification. J Biol Chem 2000;275:20197-203.
22. Narisawa S, Yadav MC, Millan JL. In vivo overexpression of tissue-nonspecific alkaline phosphatase increases skeletal mineralization and affects the phosphorylation status of osteopontin. J Bone Miner Res 2013;28:1587-98.
23. Sheen CR, Kuss P, Narisawa S, Yadav MC, Nigro J, Wang W, Chhea TN, Sergienko EA, Kapoor K, Jackson MR, et al. Pathophysiological role of vascular smooth muscle alkaline phosphatase in medial artery calcification. J Bone Miner Res 2015;30:824-36.
24. Kapustin AN, Davies JD, Reynolds JL, McNair R, Jones GT, Sidibe A, Schurgers LJ, Skepper JN, Proudfoot D, Mayr M, et al. Calcium regulates key components of vascular smooth muscle cell-derived matrix vesicles to enhance mineralization. Circ Res 2011;109: e1-12.
25. Speer MY, Yang HY, Brabb T, Leaf E, Look A, Lin WL, Frutkin A, Dichek D, Giachelli CM. Smooth muscle cells give rise to osteochondrogenic precursors and chondrocytes in calcifying arteries. Circ Res 2009;104:733-41.
26. Shao JS, Cheng SL, Pingsterhaus JM, Charlton-Kachigian N, Loewy AP, Towler DA. Msx2 promotes cardiovascular calcification by activating paracrine Wnt signals. J Clin Invest 2005;115:1210-20.
27. Albiero M, Rattazzi M, Menegazzo L, Boscaro E, Cappellari R, Pagnin E, Bertacco E, Poncina N, Dyar K, Ciciliot S, et al. Myeloid calcifying cells promote atherosclerotic calcification via paracrine activity and allograft inflammatory factor-1 overexpression. Basic Res Cardiol 2013;108:368.
28. Yao J, Guihard P, Blazquez-Medela AM, Guo Y, Moon JH, Jumabay M, Bostrom KI, Yao Y. Serine protease activation essential for endothelial-mesenchymal transition in vascular calcification. Circ Res 2015;117:758-69.
29. St. Hilaire C, Ziegler SG, Markello TC, Brusco A, Groden C, Gill F, Carlson-Donohoe H, Lederman RJ, Chen MY, Yang D, et al. NT5E mutations and arterial calcifications. N Engl J Med 2011;364:432-42.
30. Lin ME, Chen T, Leaf EM, Speer MY, Giachelli CM. Runx2 expression in smooth muscle cells is required for arterial medial calcification in mice. Am J Pathol 2015;185:1958-69.
31. Heath JM, Sun Y, Yuan K, Bradley WE, Litovsky S, Dell'Italia LJ, Chatham JC, Wu H, Chen Y. Activation of AKT by O-linked Nacetylglucosamine induces vascular calcification in diabetes mellitus. Circ Res 2014;114:1094-102.
32. Raaz U, Schellinger IN, Chernogubova E, Warnecke C, Kayama Y, Penov K, Hennigs JK, Salomons F, Eken S, Emrich FC, et al. Transcription factor Runx2 promotes aortic fibrosis and stiffness in type 2 diabetes mellitus. Circ Res 2015;117:513-24.
33. Demer LL, Tintut Y. Inflammatory, metabolic, and genetic mechanisms of vascular calcification. Arterioscler Thromb Vasc Biol 2014;34:715-23.
34. Su X, Ao L, Shi Y, Johnson TR, Fullerton DA, Meng X. Oxidized low density lipoprotein induces bone morphogenetic protein-2 in coronary artery endothelial cells via Toll-like receptors 2 and 4. J Biol Chem 2011;286:12213-20.
35. New SE, Goettsch C, Aikawa M, Marchini JF, Shibasaki M, Yabusaki K, Libby P, Shanahan CM, Croce K, Aikawa E. Macrophage-derived matrix vesicles: An alternative novel mechanism for microcalcification in atherosclerotic plaques. Circ Res 2013;113:72-7.
36. Maes C, Kobayashi T, Selig MK, Torrekens S, Roth SI, Mackem S, Carmeliet G, Kronenberg HM. Osteoblast precursors, but not mature osteoblasts, move into developing and fractured bones along with invading blood vessels. Dev Cell 2010;19:329-44.
37. Moe SM, Drueke T, Lameire N, Eknoyan G. Chronic kidney disease-mineral-bone disorder: A new paradigm. Adv Chronic Kidney Dis 2007;14:3-12.
38. Kuro-o M. Overview of the FGF23-Klotho axis. Pediatr Nephrol 2010;25:583-90.
39. Razzaque MS, Lanske B. Hypervitaminosis D and premature aging: Lessons learned from Fgf23 and Klotho mutant mice. Trends Mol Med 2006;12:298-305.
40. Jono S, Nishizawa Y, Shioi A, Morii H. Parathyroid hormone-related peptide as a local regulator of vascular calcification: Its inhibitory action on in vitro calcification by bovine vascular smooth muscle cells. Arterioscler Thromb Vasc Biol 1997;17:1135-42.
41. Shroff RC, McNair R, Figg N, Skepper JN, Schurgers L, Gupta A, Hiorns M, Donald AE, Deanfield J, Rees L, et al. Dialysis accelerates medial vascular calcification in part by triggering smooth muscle cell apoptosis. Circulation 2008;118:1748-57.
42. Foley RN. Phosphate levels and cardiovascular disease in the general population. Clin J Am Soc Nephrol 2009;4:1136-9.
43. Faul C, Amaral AP, Oskouei B, Hu MC, Sloan A, Isakova T, Gutierrez OM, Aguillon-Prada R, Lincoln J, Hare JM, et al. FGF23 induces left ventricular hypertrophy. J Clin Invest 2011;121:4393-408.
44. Wolf M. Mineral (mal)adaptation to kidney disease-young investigator award address: American Society of Nephrology Kidney Week 2014. Clin J Am Soc Nephrol 2015;10:1875-85.
45. London GM, Guerin AP, Marchais SJ, Metivier F, Pannier B, Adda H. Arterial media calcification in end-stage renal disease: Impact on allcause and cardiovascular mortality. Nephrol Dial Transplant 2003;18:1731-40.
46. London GM, Marchais SJ, Guerin AP, de Vernejoul MC. Anklebrachial index and bone turnover in patients on dialysis. J Am Soc Nephrol 2015;26:476-83.
47. London GM, Marty C, Marchais SJ, Guerin AP, Metivier F, de Vernejoul MC. Arterial calcifications and bone histomorphometry in end-stage renal disease. J Am Soc Nephrol 2004;15:1943-51.
48. Cheng SL, Shao JS, Halstead LR, Distelhorst K, Sierra O, Towler DA. Activation of vascular smooth muscle parathyroid hormone receptor inhibits Wnt/b-catenin signaling and aortic fibrosis in diabetic arteriosclerosis. Circ Res 2010;107:271-82.
49. Sebastian EM, Suva LJ, Friedman PA. Differential effects of intermittent PTH(1-34) and PTH(7-34) on bone microarchitecture and aortic calcification in experimental renal failure. Bone 2008;43:1022-30.
50. Mathew S, Davies M, Lund R, Saab G, Hruska KA. Function and effect of bone morphogenetic protein-7 in kidney bone and the bonevascular links in chronic kidney disease. Eur J Clin Invest 2006;36(Suppl 2):43-50.
51. Song GJ, Fiaschi-Taesch N, Bisello A. Endogenous parathyroid hormone-related protein regulates the expression of PTH type 1 receptor and proliferation of vascular smooth muscle cells. Mol Endocrinol 2009;23:1681-90.
52. Raison D, Coquard C, Hochane M, Steger J, Massfelder T, Moulin B, Karaplis AC, Metzger D, Chambon P, Helwig JJ, et al. Knockdown of parathyroid hormone related protein in smooth muscle cells alters renal hemodynamics but not blood pressure. Am J Physiol Renal Physiol 2013;305:F333-42.
53. Heaney RP, Kopecky S, Maki KC, Hathcock J, Mackay D, Wallace TC. A review of calcium supplements and cardiovascular disease risk. Adv Nutr 2012;3:763-71.
54. Amiri FS. Contemporary management of phosphorus retention in chronic kidney disease: A review. Clin Exp Nephrol 2015;19:985-99.
55. Raggi P, James G, Burke SK, Bommer J, Chasan-Taber S, Holzer H, Braun J, Chertow GM. Decrease in thoracic vertebral bone attenuation with calcium-based phosphate binders in hemodialysis. J Bone Miner Res 2005;20:764-72.
56. Leibrock CB, Alesutan I, Voelkl J, Pakladok T, Michael D, Schleicher E, Kamyabi-Moghaddam Z, Quintanilla-Martinez L, Kuro OM, Lang F. NH4Cl treatment prevents tissue calcification in Klotho deficiency. J Am Soc Nephrol 2015;26:2423-33.
57. Farrow EG, White KE. Recent advances in renal phosphate handling. Nat Rev Nephrol 2010;6:207-17.
58. López I, Rodriguez-Ortiz ME, Almaden Y, Guerrero F, de Oca AM, Pineda C, Shalhoub V, Rodriguez M, Aguilera-Tejero E. Direct and indirect effects of parathyroid hormone on circulating levels of fibroblast growth factor 23 in vivo. Kidney Int 2011;80:475-82.
59. Moe SM, Radcliffe JS, White KE, Gattone, 2nd VH, Seifert MF, Chen X, Aldridge B, Chen NX. The pathophysiology of early-stage chronic kidney disease-mineral bone disorder (CKD-MBD) and response to phosphate binders in the rat. J Bone Miner Res 2011;26:2672-81.
60. Kronenberg HM. PTH regulates the hematopoietic stem cell niche in bone. Adv Exp Med Biol 2007;602:57-60.
61. Napoli C, William-Ignarro S, Byrns R, Balestrieri ML, Crimi E, Farzati B, Mancini FP, de Nigris F, Matarazzo A, D'Amora M, et al. Therapeutic targeting of the stem cell niche in experimental hindlimb ischemia. Nat Clin Pract Cardiovasc Med 2008;5:571-9.
62. Rhee Y, Bivi N, Farrow E, Lezcano V, Plotkin LI, White KE, Bellido T. Parathyroid hormone receptor signaling in osteocytes increases the expression of fibroblast growth factor-23 in vitro and in vivo. Bone 2011;49:636-43.
63. Jilka RL, Almeida M, Ambrogini E, Han L, Roberson PK, Weinstein RS, Manolagas SC. Decreased oxidative stress and greater bone anabolism in the aged, when compared to the young, murine skeleton with parathyroid hormone administration. Aging Cell 2010;9:851-67.
64. Prisby R, Guignandon A, Vanden-Bossche A, Mac-Way F, Linossier MT, Thomas M, Laroche N, Malaval L, Langer M, Peter ZA, et al. Intermittent PTH(1-84) is osteoanabolic but not osteoangiogenic and relocates bone marrow blood vessels closer to bone-forming sites. J Bone Miner Res 2011;26:2583-96.
65. Weaver C, Wastney M, Spence L. Quantitative clinical nutrition approaches to the study of calcium and bone metabolism. In: Holick M, Nieves J, editors. Nutrition and Bone Health. Totowa (NJ): Humana Press; 2015. p. 361-77.
66. Fleet JC, Hong J, Zhang Z. Reshaping the way we view vitamin D signalling and the role of vitamin D in health. Nutr Res Rev 2004;17:241-8.
67. Weaver CM, Heaney RP, Teegarden D, Hinders SM. Wheat bran abolishes the inverse relationship between calcium load size and absorption fraction in women. J Nutr 1996;126:303-7.
68. Heaney RP, Recker RR, Stegman MR, Moy AJ. Calcium absorption in women: Relationships to calcium intake, estrogen status, and age. J Bone Miner Res 1989;4:469-75.
69. Heaney RP, Weaver CM, Fitzsimmons ML. Influence of calcium load on absorption fraction. J Bone Miner Res 1990;5:1135-8.
70. Weaver CM, Proulx WR, Heaney R. Choices for achieving adequate dietary calcium with a vegetarian diet. Am J Clin Nutr 1999; 70(Suppl):543S-8S.
71. Reid IR, Bolland MJ, Grey A. Effects of vitamin D supplements on bone mineral density: A systematic review and meta-analysis. Lancet 2014;383:146-55.
72. Masuyama R, Nakaya Y, Katsumata S, Kajita Y, Uehara M, Tanaka S, Sakai A, Kato S, Nakamura T, Suzuki K. Dietary calcium and phosphorus ratio regulates bone mineralization and turnover in vitamin D receptor knockout mice by affecting intestinal calcium and phosphorus absorption. J Bone Miner Res 2003;18:1217-26.
73. Bischoff-Ferrari HA, Kiel DP, Dawson-Hughes B, Orav JE, Li R, Spiegelman D, Dietrich T, Willett WC. Dietary calcium and serum 25-hydroxyvitamin D status in relation to BMD among U.S. adults. J Bone Miner Res 2009;24:935-42.
74. Tang BM, Eslick GD, Nowson C, Smith C, Bensoussan A. Use of calcium or calcium in combination with vitamin D supplementation to prevent fractures and bone loss in people aged 50 years and older: A meta-analysis. Lancet 2007;370:657-66.
75. Cauley JA. The Women's Health Initiative: Hormone therapy and calcium/vitamin D supplementation trials. Curr Osteoporos Rep 2013;11:171-8.
76. Prentice RL, Pettinger MB, Jackson RD, Wactawski-Wende J, Lacroix AZ, Anderson GL, Chlebowski RT, Manson JE, Van Horn L, Vitolins MZ, et al. Health risks and benefits from calcium and vitamin D supplementation: Women's Health Initiative clinical trial and cohort study. Osteoporos Int 2013;24:567-80.
77. Bone Health and Osteoporosis: A Surgeon General's Report. US Public Health Service. 2004. Office of the Surgeon General (US). Bone health and osteoporosis: a report of the surgeon general. Rockville (MD): Office of the Surgeon General (US); 2004. [cited 2015 Jan 8]. Available from: http://www.ncbi.nlm.nih.gov/books/NBK45513/.
78. Moyer VA. Force* USPST. Vitamin D and calcium supplementation to prevent fractures in adults: U.S. Preventive Services Task Force recommendation statement. Ann Intern Med 2013;158:691-6.
79. Bauer DC. Clinical practice: Calcium supplements and fracture prevention. N Engl J Med 2013;369:1537-43.
80. Phillips A, Lipkie T, Weaver C. Calcium and vitamin D: Nutrition role and the benefits and risks of dietary supplements in health promotion. In: Wallace T, editor. Dietary Supplements in Health Promotion. Boca Raton (FL): CRC Press; 2015. p. 121-35.
81. Park CY, Lee WH, Fleet JC, Allen MR, McCabe GP, Walsh DM, Weaver CM. Calcium and vitamin D intake maintained from preovariectomy independently affect calcium metabolism and bone properties in Sprague Dawley rats. Osteoporos Int 2014;25:1905-15.
82. Bolland MJ, Barber PA, Doughty RN, Mason B, Horne A, Ames R, Gamble GD, Grey A, Reid IR. Vascular events in healthy older women receiving calcium supplementation: Randomised controlled trial. BMJ 2008;336:262-6.
83. Bolland MJ, Avenell A, Baron JA, Grey A, MacLennan GS, Gamble GD, Reid IR. Effect of calcium supplements on risk of myocardial infarction and cardiovascular events: Meta-analysis. BMJ 2010;341: c3691.
84. Weaver CM. Calcium supplementation: Is protecting against osteoporosis counter to protecting against cardiovascular disease? Curr Osteoporos Rep 2014;12:211-8.
85. Michaëlsson K, Melhus H, Warensjo Lemming E, Wolk A, Byberg L. Long term calcium intake and rates of all cause and cardiovascular mortality: Community based prospective longitudinal cohort study. BMJ 2013;346:f228.
86. Van Hemelrijck M, Michaelsson K, Linseisen J, Rohrmann S. Calcium intake and serum concentration in relation to risk of cardiovascular death in NHANES III. PLoS One 2013;8:e61037.
87. Wastney M, Lee W, Jackson GS, Alloosh M, Sturek M, Lachcik P, Peacock M, Martin B, Weaver CM. Soft tissue calcification in the Ossabaw miniature pig: Experimental and kinetic modeling studies. Osteoporos Int 2013;24:2123-6.
88. Phillips-Eakley AK, McKenney-Drake ML, Bahls M, Newcomer SC, Radcliffe JS, Wastney ME, Van Alstine WG, Jackson G, Alloosh M, Martin BR, et al. Effect of high-calcium diet on coronary artery disease in Ossabaw miniature swine with metabolic syndrome. J Am Heart Assoc 2015;4.
89. Dietary Guidelines: Advisory Report [Internet]. Rockville (MD): Office of Disease Prevention and Health Promotion. 2015 [cited 2015 Jan 8]. Available from: http://www.health.gov/dietaryguidelines/2015-scientific-report/.
90. Ross AC, Taylor C, Yaktine A, Del Valle H. Dietary Reference Intakes for Calcium and Vitamin D. Washington (DC): Institute of Medicine, National Academy Press; 2011.
91. Hill KM, Martin BR, Wastney ME, McCabe GP, Moe SM, Weaver CM, Peacock M. Oral calcium carbonate affects calcium but not phosphorus balance in stage 3-4 chronic kidney disease. Kidney Int 2013;83:959-66.
92. Aloia JF, Vaswani A, Yeh JK, Ellis K, Cohn SH. Total body phosphorus in postmenopausal women. Miner Electrolyte Metab 1984;10:73-6.
93. Kalantar-Zadeh K, Gutekunst L, Mehrotra R, Kovesdy CP, Bross R, Shinaberger CS, Noori N, Hirschberg R, Benner D, Nissenson AR, et al. Understanding sources of dietary phosphorus in the treatment of patients with chronic kidney disease. Clin J Am Soc Nephrol 2010;5:519-30.
94. Kidney Disease Improving Global Outcomes, C.K.D.M.B.D. Work Group. KDIGO clinical practice guideline for the diagnosis, evaluation, prevention, and treatment of chronic kidney disease-mineral and bone disorder (CKD-MBD). Kidney Int Suppl 2009;76 (Suppl 113):S1-S130.
95. Foley RN, Parfrey PS, Sarnak MJ. Clinical epidemiology of cardiovascular disease in chronic renal disease. Am J Kidney Dis 1998; 32(Suppl 3)S112-9.
96. Alem AM, Sherrard DJ, Gillen DL, Weiss NS, Beresford SA, Heckbert SR, Wong C, Stehman-Breen C. Increased risk of hip fracture among patients with end-stage renal disease. Kidney Int 2000;58:396-9.
97. Heaney RP, Recker RR. Effects of nitrogen, phosphorus, and caffeine on calcium balance in women. J Lab Clin Med 1982;99:46-55.
98. Spencer H, Menczel J, Lewin I, Samachson J. Effect of high phosphorus intake on calcium and phosphorus metabolism in man. J Nutr 1965;86:125-32.
99. Institute of Medicine. DRI: Dietary Reference Intakes for calcium, phosphorus, magnesium, vitamin D, and fluoride. Washington (DC): National Academy Press; 1997.
100. Martin KJ, Gonzalez EA. Prevention and control of phosphate retention/hyperphosphatemia in CKD-MBD: What is normal, when to start, and how to treat? Clin J Am Soc Nephrol 2011;6:440-6.
101. Li JW, Xu C, Fan Y, Wang Y, Xiao YB. Can serum levels of alkaline phosphatase and phosphate predict cardiovascular diseases and total mortality in individuals with preserved renal function? A systemic review and meta-analysis. PLoS One 2014;9:e102276.
102. Dhingra R, Sullivan LM, Fox CS, Wang TJ, D'Agostino RB, Sr., Gaziano JM, Vasan RS. Relations of serum phosphorus and calcium levels to the incidence of cardiovascular disease in the community. Arch Intern Med 2007;167:879-85.
103. Tonelli M, Sacks F, Pfeffer M, Gao Z, Curhan G. Cholesterol, Recurrent Events Trial I: Relation between serum phosphate level and cardiovascular event rate in people with coronary disease. Circulation 2005;112:2627-33.
104. Palmer SC, Hayen A, Macaskill P, Pellegrini F, Craig JC, Elder GJ, Strippoli GF. Serum levels of phosphorus, parathyroid hormone, and calcium and risks of death and cardiovascular disease in individuals with chronic kidney disease: A systematic review and meta-analysis. JAMA 2011;305:1119-27.
105. Kestenbaum B, Sampson JN, Rudser KD, Patterson DJ, Seliger SL, Young B, Sherrard DJ, Andress DL. Serum phosphate levels and mortality risk among people with chronic kidney disease. J Am Soc Nephrol 2005;16:520-8.
106. Hill Gallant KM. Studying dietary phosphorus intake: The challenge of when a gram is not a gram. Am J Clin Nutr 2015;102:237-8.
107. Chang AR, Lazo M, Appel LJ, Gutierrez OM, Grams ME. High dietary phosphorus intake is associated with all-cause mortality: Results from NHANES III. Am J Clin Nutr 2014;99:320-7.
108. Murtaugh MA, Filipowicz R, Baird BC, Wei G, Greene T, Beddhu S. Dietary phosphorus intake and mortality in moderate chronic kidney disease: NHANES III. Nephrol Dial Transplant 2012;27:990-6.
109. Yamamoto KT, Robinson-Cohen C, de Oliveira MC, Kostina A, Nettleton JA, Ix JH, Nguyen H, Eng J, Lima JA, Siscovick DS, et al. Dietary phosphorus is associated with greater left ventricular mass. Kidney Int 2013;83:707-14.
110. Leopold JA. Vascular calcification: Mechanisms of vascular smooth muscle cell calcification. Trends Cardiovasc Med 2015;25:267-74.
111. Moe SM, Chen NX, Seifert MF, Sinders RM, Duan D, Chen X, Liang Y, Radcliff JS, White KE, Gattone, 2nd VH. A rat model of chronic kidney disease-mineral bone disorder. Kidney Int 2009;75:176-84.
112. Report from the Strategic Planning Advisory Panel on Health Disparities: NIH Publication No. 99-4566. Bethesda (MD): National Institutes of Health; 2013.
113. Unequal Treatment: Confronting Racial and Ethnic Disparities in Health Care. In: Smedley BDSA, Nelso AR, editors. Washington (DC): Institutes of Medicine; 2002.
114. What Is Osteoporosis? [Internet]. Bethesda (MD): Osteoporosis and Related Bone Diseases National Resource Center, National Institutes of Health. 2011 [cited 2014 Feb 6]. Available from: http://www.niams. nih.gov/Health_Info/Bone/Osteoporosis/osteoporosis_ff.asp.
115. Wright NC, Looker AC, Saag KG, Curtis JR, Delzell ES, Randall S, Dawson-Hughes B. The recent prevalence of osteoporosis and low bone mass in the United States based on bone mineral density at the femoral neck or lumbar spine. J Bone Miner Res 2014;29:2520-6.
116. Vásquez E, Shaw BA, Gensburg L, Okorodudu D, Corsino L. Racial and ethnic differences in physical activity and bone density: National Health and Nutrition Examination Survey, 2007-2008. Prev Chronic Dis 2013;10:E216.
117. Bailey RL, Dodd KW, Goldman JA, Gahche JJ, Dwyer JT, Moshfegh AJ, Sempos CT, Picciano MF. Estimation of total usual calcium and vitamin D intakes in the United States. J Nutr 2010;140:817-22.
118. Bailey RL, Fulgoni, 3rd VL, Keast DR, Lentino CV, Dwyer JT. Do dietary supplements improve micronutrient sufficiency in children and adolescents? J Pediatr 2012;161:837-42.
119. Wallace TC, Reider C, Fulgoni, 3rd VL. Calcium and vitamin D disparities are related to gender, age, race, household income level, and weight classification but not vegetarian status in the United States: Analysis of the NHANES 2001-2008 data set. J Am Coll Nutr 2013;32:321-30.
120. Bailey RK, Fileti CP, Keith J, Tropez-Sims S, Price W, Allison-Ottey SD. Lactose intolerance and health disparities among African Americans and Hispanic Americans: An updated consensus statement. J Natl Med Assoc 2013;105:112-27.
121. Walker MD, Novotny R, Bilezikian JP, Weaver CM. Race and diet interactions in the acquisition, maintenance, and loss of bone. J Nutr 2008;138:1256S-60S.
122. Braun M, Palacios C, Wigertz K, Jackman LA, Bryant RJ, McCabe LD, Martin BR, McCabe GP, Peacock M, Weaver CM. Racial differences in skeletal calcium retention in adolescent girls with varied controlled calcium intakes. Am J Clin Nutr 2007;85:1657-63.
123. Powe CE, Evans MK, Wenger J, Zonderman AB, Berg AH, Nalls M, Tamez H, Zhang D, Bhan I, Karumanchi SA, et al. Vitamin D-binding protein and vitamin D status of black Americans and white Americans. N Engl J Med 2013;369:1991-2000.
124. Lutsey PL, Michos ED, Misialek JR, Pankow JS, Loehr L, Selvin E, Reis JP, Gross M, Eckfeldt JH, Folsom AR. Race and vitamin D binding protein gene polymorphisms modify the association of 25-hydroxyvitamin D and incident heart failure: The ARIC (Atherosclerosis Risk in Communities) Study. JACC Heart Fail 2015;3:347-56.
125. Reis JP, Michos ED, Selvin E, Pankow JS, Lutsey PL. Race, vitamin D-binding protein gene polymorphisms, 25-hydroxyvitamin D, and incident diabetes: The Atherosclerosis Risk in Communities (ARIC) Study. Am J Clin Nutr 2015;101:1232-40.
126. Sonderman JS, Munro HM, Blot WJ, Signorello LB. Reproducibility of serum 25-hydroxyvitamin D and vitamin D-binding protein levels over time in a prospective cohort study of black and white adults. Am J Epidemiol 2012;176:615-21.
127. Ponda MP, McGee D, Breslow JL. Vitamin D-binding protein levels do not influence the effect of vitamin D repletion on serum PTH and calcium: Data from a randomized, controlled trial. J Clin Endocrinol Metab 2014;99:2494-9.
128. Paik JM, Farwell WR, Taylor EN. Demographic, dietary, and serum factors and parathyroid hormone in the National Health and Nutrition Examination Survey. Osteoporos Int 2012;23:1727-36.
129. Cauley JA, Lui LY, Ensrud KE, Zmuda JM, Stone KL, Hochberg MC, Cummings SR. Bone mineral density and the risk of incident nonspinal fractures in black and white women. JAMA 2005;293:2102-8.
130. Ogden CL, Carroll MD, Flegal KM. Prevalence of obesity in the United States. JAMA 2014;312:189-90.
131. Center for Disease Control and Prevention. Deaths, percent of total deaths, and death rates for the 15 leading causes of death in 10-year age groups, by race and sex: United States. 2013. [cited 2015 Jan 8]. Available from: http://www.cdc.gov/nchs/data/dvs/lcwk2_2013.pdf.
132. Go AS, Mozaffarian D, Roger VL, Benjamin EJ, Berry JD, Blaha MJ, Dai S, Ford ES, Fox CS, Franco S, et al. Heart disease and stroke statistics-2014 update: A report from the American Heart Association. Circulation 2014;129:e28-292.
133. Stamler J, Brown IJ, Yap IK, Chan Q, Wijeyesekera A, Garcia-Perez I, Chadeau-Hyam M, Ebbels TM, De Iorio M, Posma J, et al. Dietary and urinary metabonomic factors possibly accounting for higher blood pressure of black compared with white Americans: Results of International Collaborative Study on macro-/micronutrients and blood pressure. Hypertension 2013;62:1074-80.
134. Sharma S, Cruickshank JK, Green DM, Vik S, Tome A, Kolonel LN. Impact of diet on mortality from stroke: Results from the U.S. multiethnic cohort study. J Am Coll Nutr 2013;32:151-9.